The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) are soliciting proposals from small businesses that possess capabilities to conduct innovative research that will contribute toward meeting the program objectives of the agencies.
Highlighted topic areas include:
Integrated Multiplex Medical Diagnostics Platforms for Infectious Diseases
Assay Development for High-Throughput Screening of Chemicals of Toxicological Concern
Development of Nanoparticle Dengue Diagnostic Tests
Aerosolized Delivery of Anti-Tubercular Drugs
Improved Formulations for Approved First and Second line anti-Tuberculosis (TB) Drugs
Diagnostic Needs for Neglected Tropical Diseases (NTD) Programs
Rapid Screening Tests to Prevent Congenital Infections and Ensure Blood Safety
Development of User-Friendly Diagnostics of Arboviral Infections in Resource-Limited Settings
Visualizing Knowledge about Human Health and the Pathways of Translation
Automated Instrument to Clean Microtiter Plates
Technology to Generate Anti-Peptide Capture Reagents for Affinity-Enriched Proteomic Studies
Improving Safety and Efficacy of Red Blood Cells for Transfusion
Fluorescent Nanodiamonds for In Vitro and In Vivo Biological Imaging
Development of an Inactivated Rotavirus Vaccine for Use in Global Immunization
Thermostable Dry Measles Vaccine Formulation for Sublingual Administration
This activity, as part of the Small Business Innovation Research (SBIR) program, is designed to stimulate technological innovation in the private sector; strengthen the role of small business in meeting Federal research needs; and increase the commercial application of Federally-supported research results.
Additional topics are available under PHS-2013-1. The agencies will post a full solicitation on or about August 15, 2012 and begin accepting proposals at that time. The deadline for submission is November 13, 2012.
